UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro Expansion

Stem cells (Dayton, Ohio), 2004-09, Vol.22 (5), p.675-682

2004

Volltextzugriff (PDF)

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

Blood, 2004-11, Vol.104 (9), p.2643-2645

2004

Volltextzugriff (PDF)

Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI

Virology journal, 2006-03, Vol.3 (1), p.14-14, Article 14

2006

Volltextzugriff (PDF)

Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer

American Journal of Physiology: Cell Physiology, 2003-09, Vol.285 (3), p.C584-C591

2003

Volltextzugriff (PDF)

Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-α on Fanconi anemia hematopoietic stem and progenitor cells

Blood, 2009-05, Vol.113 (21), p.5111-5120

2009

Volltextzugriff (PDF)

The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine

The journal of gene medicine, 2006-01, Vol.8 (1), p.29

2006

Volltextzugriff (PDF)

Protection and selection for gene therapy in the hematopoietic system

The journal of gene medicine, 2004-02, Vol.6 (2), p.133-146

2004

Volltextzugriff (PDF)

High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: potential targets for in utero ex vivo gene therapy

BJOG : an international journal of obstetrics and gynaecology, 2002-08, Vol.109 (8), p.952-954

2002

Volltextzugriff (PDF)

Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase

The journal of gene medicine, 2006-05, Vol.8 (5), p.557-565

2006

Volltextzugriff (PDF)

Retrovirally mediated correction of bone marrow–derived mesenchymal stem cells from patients with mucopolysaccharidosis type I

Blood, 2002-03, Vol.99 (5), p.1857-1859

2002

Volltextzugriff (PDF)

Genetic manipulation of drug sensitivity in haematopoietic cells

Expert reviews in molecular medicine, 2004-08, Vol.6 (18), p.1-24

2004

Volltextzugriff (PDF)

Total Deletion of in Vivo Telomere Elongation Capacity: An Ambitious but Possibly Ultimate Cure for All Age-Related Human Cancers

Annals of the New York Academy of Sciences, 2004-06, Vol.1019 (1), p.147-170

2004

Volltextzugriff (PDF)

Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase

The journal of gene medicine, 2006-08, Vol.8 (8), p.972-979

2006

Volltextzugriff (PDF)

669. Drug Selection of Hematopoietic Cells by Regulated MGMT Activity

Molecular therapy, 2006-05, Vol.13 (S1), p.S258-S258

2006

Volltextzugriff (PDF)

Erratum to “Enhanced in Vivo Selection of Bone Marrow Cells by Retroviral-Mediated Coexpression of Mutant O6-Methylguanine-DNA-methyltransferase and HOXB4”

Molecular therapy, 2005-10, Vol.12 (4), p.772-773

2005

Volltextzugriff (PDF)

Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4

Molecular therapy, 2004-11, Vol.10 (5), p.862-873

2004

Volltextzugriff (PDF)

The P140K mutant of human O6-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O6-(4-bromothenyl)guanine

The journal of gene medicine, 2006-01, Vol.8 (1), p.29-34

2006

Volltextzugriff (PDF)

Prospects for gene therapy using haemopoietic stem cells

Best practice & research. Clinical haematology, 2001-12, Vol.14 (4), p.823-834

2001

Volltextzugriff (PDF)

Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide

Cancer gene therapy, 2000-02, Vol.7 (2), p.233-239

2000

Volltextzugriff (PDF)

bcl-2 delay of alkylating agent-induced apoptotic death in a murine hemopoietic stem cell line

Molecular carcinogenesis, 1994-09, Vol.11 (1), p.49-55

1994

Volltextzugriff (PDF)

How do stem cells decide what to do?

Current opinion in oncology, 1992-12, Vol.4 (6 Suppl 1), p.S11-S12

1992

Volltextzugriff (PDF)

1044. Radioprotective Gene Therapy through Retroviral Expression of Manganese Superoxide Dismutase

Molecular therapy, 2005-05, Vol.11 (S1), p.S404-S404

2005

Volltextzugriff (PDF)

Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P [sub]140K mutant of O [sup]6-methylguanine-DNA-methyl transferase

The journal of gene medicine, 2006-08, Vol.8 (8), p.972

2006

Volltextzugriff (PDF)

Dual agent chemoprotection by retroviral co‐expression of either MDR1 or MRP1 with the P 140 K mutant of O 6 ‐methylguanine‐DNA‐methyl transferase

The journal of gene medicine, 2006-08, Vol.8 (8), p.972-979

2006

Volltextzugriff (PDF)

Development of Novel Multigene Lentiviral Vectors

Blood, 2004-11, Vol.104 (11), p.5272-5272

2004

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro Expansion

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI

Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer

Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-α on Fanconi anemia hematopoietic stem and progenitor cells

The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine

Protection and selection for gene therapy in the hematopoietic system

High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: potential targets for in utero ex vivo gene therapy

Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase

Retrovirally mediated correction of bone marrow–derived mesenchymal stem cells from patients with mucopolysaccharidosis type I

Genetic manipulation of drug sensitivity in haematopoietic cells

Total Deletion of in Vivo Telomere Elongation Capacity: An Ambitious but Possibly Ultimate Cure for All Age-Related Human Cancers

Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase

669. Drug Selection of Hematopoietic Cells by Regulated MGMT Activity

Erratum to “Enhanced in Vivo Selection of Bone Marrow Cells by Retroviral-Mediated Coexpression of Mutant O6-Methylguanine-DNA-methyltransferase and HOXB4”

Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4

The P140K mutant of human O6-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O6-(4-bromothenyl)guanine

Prospects for gene therapy using haemopoietic stem cells

Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide

bcl-2 delay of alkylating agent-induced apoptotic death in a murine hemopoietic stem cell line

How do stem cells decide what to do?

1044. Radioprotective Gene Therapy through Retroviral Expression of Manganese Superoxide Dismutase

Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P [sub]140K mutant of O [sup]6-methylguanine-DNA-methyl transferase

Dual agent chemoprotection by retroviral co‐expression of either MDR1 or MRP1 with the P 140 K mutant of O 6 ‐methylguanine‐DNA‐methyl transferase

Development of Novel Multigene Lentiviral Vectors

Suchergebnisse filtern